New COVID vaccine says it’s for the ‘senior class’ — does it reduce side effects?
- Posted on October 28, 2025
- By San Francisco Chronicle
- 4 Views
New COVID vaccine says it’s for the ‘senior class’ — does it reduce side effects?
The new Moderna COVID vaccine, mNexspike, is approved for adults 65 and older and people 12 to 64 with an underlying medical condition that puts them at higher risk for severe COVID.
